In 2025, everything suggested that our work would have to scale back. Institutional funding declined. Yet 8.9 million people benefited from our programs last year, compared to 6.7 million in 2024.
This was possible because ALIMA chose to broaden its horizons. The organization sought new funding from private partners and diversified its resources. While some projects came to an end, others intensified to meet humanitarian needs, thanks to local roots that allow us to continue working where others no longer can.
Providing Care: 8.9 Million People Reached
The year 2025 began with fighting in Goma, in the Democratic Republic of the Congo (DRC), and ended with an Ebola outbreak in Kasaï brought under control within three months. In between came the mass displacement of people in North Darfur, Sudan, a cholera outbreak in Tawila, and a surge in malaria cases in South Sudan.
With each crisis, our teams responded to the emergency without losing sight of the long term: training local healthcare workers, advancing medical research, and reducing the environmental impact of our work. This dual commitment to addressing both urgent and long-term needs is what makes our action sustainable.
Behind these efforts are lives impacted:
- 8.9 million beneficiaries
- 54 medical projects carried out across 14 countries
- 230,818 malnourished children treated
- 98,181 assisted births
- 73,031 mental health consultations provided
- 5 outbreak responses: meningitis in Nigeria, Mpox and Ebola in the DRC, and cholera in Sudan and Chad
- An annual budget of €74.7 million, with 92% dedicated to social missions
Beyond the figures, there is Zawadi, shot in Goma, DRC, and treated by our surgical teams. There is three-year-old Aminata in Mali, who is regaining her strength thanks to ready-to-use therapeutic food. And there is Wisal, an internally displaced Sudanese woman who reached Tawila on foot with her family and now works as a nutrition assistant on our medical team.
Together: The Strength of Local Partners
We work alongside local NGOs, ministries of health, researchers, and communities. ALIMA’s model is built on a strong alliance between local and international actors, with 95% of our team coming from the countries where we operate, enabling more effective collaboration in the field and access to the most isolated areas.
📍 Democratic Republic of the Congo: In Kasaï, an Ebola outbreak was contained within three months in a hard-to-reach area, thanks to the collective efforts of the authorities, local doctors, communities, and international NGOs, including ALIMA.
📍 Sudan: In Tawila, North Darfur, over 70% of our medical team is made up of internally displaced people, who now provide care for their own communities in overwhelmed health facilities.
📍 Mali: With our national partner AMCP-SP, the simplified OptiMA approach enabled 14,002 children to receive treatment, thanks to early malnutrition screening carried out by mothers themselves, using the MUAC for Mothers bracelet.
📍 Haiti: In Anse-à-Pitres, on the border with the Dominican Republic, where access to healthcare is extremely limited, ALIMA launched a project to improve access to medical care for deported people and the entire population living in the border area.
📍 Central African Republic: In Bimbo and Boda, performance-based financing is strengthening the healthcare system over the long term, with 27,089 mothers trained in the family MUAC for Mothers approach and 25,946 assisted births across the country,
📍 Cameroon: In the Far North region, together with our local partner DEMTOU Humanitaire, our teams are responding to the needs of populations affected by violence in the Lake Chad Basin, with 143,127 patients treated in the country.
Innovating: Research for Better Care
In 2025, ALIMA conducted 11 research projects, from a clinical trial on Lassa fever to simplified treatment protocols for malnutrition. These are all studies designed in the field, with local teams, to address needs that humanitarian medicine does not yet cover.
📍 Chad: In Ngouri, the RISQ research project is testing a scoring tool designed to assess children more accurately and identify the most severely malnourished patients as soon as they arrive at a health center.
📍 Nigeria: In response to Lassa fever, an often fatal disease with very limited treatment options, the international INTEGRATE clinical trial was launched at two sites, in Owo and Irrua, to evaluate new treatments.
📍 Guinea: The EBO-PEP study is assessing whether post-exposure treatment can prevent Ebola infection, offering a potential new tool in the fight against epidemics.
📍 Niger: In Mirriah, the OPTIMAX research project combines nutritional supplementation and vaccination to strengthen pediatric monitoring. In 2025, the study, conducted with our local partner BEFEN targeted 6,418 children.
📍 Burkina Faso: An innovative project is promoting the use of multiple micronutrient supplements to improve the health of pregnant women and newborns, with support from our local partners Keoogo and SOS Médecins BF.
An Alliance Stronger Than the Crises
“Thank you to everyone who made this year possible: our partners, teams, and donors. But our greatest gratitude goes to the patients. As the first victims of these crises, they have shown dignity and courage that give full meaning to our commitment. It is for them and with them that we will continue fighting to ensure the right to quality care.
Dr. Jean-Paul Mushenvula, President of ALIMA
If 2025 was a year of resistance, 2026 must be a year of consolidation and hope. The challenges we face are immense, but so is our collective ability to overcome them.”
> Discover ALIMA’s 2025 Annual Report.
